-
-
-
-
-
-
-
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
-
-
-
-
-
-
-
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025
-
-
-
-
-
-
-
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
NeuroOne Medical (NMTC) Reports Q4 Net Loss of $2.6M
-
1,231,971 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


